Is intravenous recombinant plasminogen activator effective up to 4.5 h after onset of ischemic stroke?
Randomized, controlled trials and subsequent observational studies in routine clinical practice have shown that intravenous recombinant tissue plasminogen activator is safe and effective when used in selected patients within 3h of the onset of acute ischemic stroke. Results of the ECASS III (Europea...
| Egile nagusia: | |
|---|---|
| Formatua: | Journal article |
| Hizkuntza: | English |
| Argitaratua: |
2009
|